Company: REVB
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034584
Chunk: 204

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 1B
Chunk 204
---
 Stock Purchase Warrant dated January 25, 2022

    4.5(5)
     
    Form of Unregistered Class A Placement Agent Warrant dated January 25, 2022

    4.6(6)
     
    Form of Class B Common Stock Warrant dated July 28, 2022

    4.7(6)
     
    Form of Class B Placement Agent Common Stock Purchase Warrant dated July 28, 2022

    4.8(6)
     
    Warrant Agency Agreement with Continental Stock Transfer & Trust Co. dated July 28, 2022

    4.9(7)
     
    Form of Class C Common Stock Warrant dated February 13, 2023

    4.10(7)
     
    Form of Warrant Agency Agreement with Continental Stock Transfer & Trust Co. dated February 13, 2023

    4.11(8)
     
    Form of Class D Common Stock Warrant dated February 5, 2024

    4.12(8)
     
    Form of Warrant Agency Agreement with Continental Stock Transfer & Trust Co. dated February 5, 2024

    4.13(9)
     
    Form of Class E Common Stock Warrant dated August 22, 2024

    4.14(10)
     
    Form of Class F Common Stock Warrant dated December 3, 2024

    4.15(10)
     
    Form of Class G Common Stock Warrant dated December 3, 2024

    4.16*
     
    Description of Securities

    10.1†(11)
     
    Revelation Biosciences, Inc. 2021 Equity Incentive Plan, as amended

    10.2†(1)
     
    Executive Employment Agreement between Revelation Biosciences, Inc. and James Rolke, effective July 27, 2021

    10.3†(1)
     
    Executive Employment Agreement between Revelation Biosciences, Inc. and Chester S. Zygmont, III, effective July 27, 2021

    10.4(1)
     
    Revelation Common Stock Warrant Issued to National Securities Corporation

    10.5(5)
     
    Securities Purchase Agreement dated January 23, 2022 by and